(Q81895322)

English

RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer

scientific article published on 01 August 2008

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

title

RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

phase III clinical trial

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

1

Joyce A O'Shaughnessy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

author name string

Adam M Brufsky

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

publication date

1 August 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

published in

Clinical Breast Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

page(s)

370-373

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

Identifiers

DOI

10.3816/CBC.2008.N.045

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

PubMed publication ID

18757267

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18757267

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18757267%20AND%20SRC:MED&resulttype=core&format=json

(Q81895322)

RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)